KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to $27.9 million.

  • Astrana Health's Depreciation & Amortization (CF) rose 11470.26% to $15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.5 million, marking a year-over-year increase of 5169.82%. This contributed to the annual value of $27.9 million for FY2024, which is 5735.29% up from last year.
  • Per Astrana Health's latest filing, its Depreciation & Amortization (CF) stood at $27.9 million for FY2024, which was up 5735.29% from $17.7 million recorded in FY2023.
  • Astrana Health's Depreciation & Amortization (CF)'s 5-year high stood at $27.9 million during FY2024, with a 5-year trough of $17.5 million in FY2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $19.8 million, with a median of $17.7 million in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 453.95% in 2021, then skyrocketed by 5735.29% in 2024.
  • Astrana Health's Depreciation & Amortization (CF) (Annual) stood at $18.3 million in 2020, then fell by 4.54% to $17.5 million in 2021, then rose by 0.15% to $17.5 million in 2022, then increased by 1.17% to $17.7 million in 2023, then skyrocketed by 57.35% to $27.9 million in 2024.
  • Its last three reported values are $27.9 million in FY2024, $17.7 million for FY2023, and $17.5 million during FY2022.